These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 18180555
21. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Liu CY, Yen CC, Chen WM, Chen TH, Chen PC, Wu HT, Shiau CY, Wu YC, Liu CL, Tzeng CH. Ann Surg Oncol; 2010 Aug; 17(8):2102-11. PubMed ID: 20217247 [Abstract] [Full Text] [Related]
22. [Treatment and prognosis of soft tissue sarcoma]. Wang Y, Shen Z, Zhang R. Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):29-32. PubMed ID: 9275684 [Abstract] [Full Text] [Related]
23. Malignant fibrous histiocytoma of the spine: a series of 13 clinical case reports and review of 17 published cases. Teng H, Xinghai Y, Wei H, Huang Q, Xiao J, Zhang C. Spine (Phila Pa 1976); 2011 Oct 15; 36(22):E1453-62. PubMed ID: 21343863 [Abstract] [Full Text] [Related]
24. Results of surgery for malignant fibrous histiocytomas of soft tissue. Matsumoto S, Ahmed AR, Kawaguchi N, Manabe J, Matsushita Y. Int J Clin Oncol; 2003 Apr 15; 8(2):104-9. PubMed ID: 12720103 [Abstract] [Full Text] [Related]
25. Why do patients with low-grade soft tissue sarcoma die? Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF. Ann Surg Oncol; 2008 Dec 15; 15(12):3550-60. PubMed ID: 18830667 [Abstract] [Full Text] [Related]
26. [An analysis of prognostic factors for malignant fibrous histiocytoma of bone]. Li GX, Guo W, Yang RL, Qu HY, Tang S, Qi DW. Zhonghua Wai Ke Za Zhi; 2011 Aug 01; 49(8):733-6. PubMed ID: 22168940 [Abstract] [Full Text] [Related]
27. Malignant fibrous histiocytoma: outcome of tumours in the head and neck compared with those in the trunk and extremities. Sabesan T, Xuexi W, Yongfa Q, Pingzhang T, Ilankovan V. Br J Oral Maxillofac Surg; 2006 Jun 01; 44(3):209-12. PubMed ID: 16026908 [Abstract] [Full Text] [Related]
28. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases. Vodanovich DA, Spelman T, May D, Slavin J, Choong PFM. ANZ J Surg; 2019 Sep 01; 89(9):1045-1050. PubMed ID: 31364245 [Abstract] [Full Text] [Related]
29. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
30. Prognosis of solitary fibrous tumors: a multicenter study. van Houdt WJ, Westerveld CM, Vrijenhoek JE, van Gorp J, van Coevorden F, Verhoef C, van Dalen T. Ann Surg Oncol; 2013 Dec 15; 20(13):4090-5. PubMed ID: 24052313 [Abstract] [Full Text] [Related]
31. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E, Barisella M, Sangalli C, Mariani L, Casali PG, Gronchi A. Ann Surg Oncol; 2011 Mar 15; 18(3):720-5. PubMed ID: 20878245 [Abstract] [Full Text] [Related]
32. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Zagars GK, Mullen JR, Pollack A. Int J Radiat Oncol Biol Phys; 1996 Mar 15; 34(5):983-94. PubMed ID: 8600111 [Abstract] [Full Text] [Related]
33. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes. Winchester D, Lehman J, Tello T, Chimato N, Hocker T, Kim S, Chang J, Markey J, Yom SS, Ryan W, Mully T, Hodge D, Otley C, Arron ST. J Am Acad Dermatol; 2018 Nov 15; 79(5):853-859. PubMed ID: 29787841 [Abstract] [Full Text] [Related]
34. Anticipated intraoperative electron beam boost, external beam radiation therapy, and limb-sparing surgical resection for patients with pediatric soft-tissue sarcomas of the extremity: a multicentric pooled analysis of long-term outcomes. Sole CV, Calvo FA, Polo A, Cambeiro M, Alvarez A, Gonzalez C, Gonzalez J, San Julian M, Martinez-Monge R. Int J Radiat Oncol Biol Phys; 2014 Sep 01; 90(1):172-80. PubMed ID: 25195992 [Abstract] [Full Text] [Related]
35. Management of patients with retroperitoneal tumors and a review of the literature. Gemici K, Buldu İ, Acar T, Alptekin H, Kaynar M, Tekinarslan E, Karatağ T, Efe D, Çolak H, Küçükkartallar T, İstanbulluoğlu MO. World J Surg Oncol; 2015 Apr 09; 13():143. PubMed ID: 25881253 [Abstract] [Full Text] [Related]
36. Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults. Tran PT, Hara W, Su Z, Lin HJ, Bendapudi PK, Norton J, Teng N, King CR, Kapp DS. Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1146-53. PubMed ID: 18394818 [Abstract] [Full Text] [Related]
37. Primary pleomorphic malignant fibrous histiocytoma of the heart. Wang J, Jiang Y, Wang Y, Yu W, Zhao P, Li Y, Lin D, Xin F. Acta Histochem; 2013 Sep 15; 115(7):761-6. PubMed ID: 23566556 [Abstract] [Full Text] [Related]
38. Treatment results and prognostic factors in patients with malignant fibrous histiocytoma. Hsu HC, Huang EY, Wang CJ. Acta Oncol; 2004 Sep 15; 43(6):530-5. PubMed ID: 15370609 [Abstract] [Full Text] [Related]
39. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Pezzi CM, Rawlings MS, Esgro JJ, Pollock RE, Romsdahl MM. Cancer; 1992 Apr 15; 69(8):2098-103. PubMed ID: 1311983 [Abstract] [Full Text] [Related]
40. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Alldinger I, Yang Q, Pilarsky C, Saeger HD, Knoefel WT, Peiper M. Anticancer Res; 2006 Apr 15; 26(2B):1577-81. PubMed ID: 16619574 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]